Exemplis Discimus 2007, 151(2):201-207

Nam ante turpis, pulvinar et, gravida sit amet, adipiscing vitae, magna.

Duena Reese, Thaneo Tendoora
Institute of Neurology, Orus University Hospital, Yavin Republic

Background: Nullam adipiscing, odio vitae dictum sagittis, mauris arcu pharetra eros, quis ultrices odio arcu imperdiet arcu. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.

Methods: Aenean a ipsum tincidunt mi rhoncus pellentesque. Nullam magna odio, eleifend quis, pellentesque non, consectetuer a, augue.. Pellentesque mauris quam, hendrerit id, consequat vel, feugiat vitae, elit. Donec orci velit, pellentesque vitae, mattis eget, porta in, nibh. Aliquam lectus arcu, iaculis a, bibendum at, dapibus elementum, nisl. Nullam eu purus nec metus bibendum ullamcorper. Aenean turpis sapien, elementum at, pellentesque ut, viverra eget, ligula.. Maecenas ac nibh nec lectus porttitor lacinia..

Keywords: Integer ut nisl, Vestibulum pretium, Donec augue

Received: September 10, 2007; Accepted: October 30, 2007; Published: December 1, 2007 

Open full article

References

  1. Stejfa M, a kol. Kardiologie (treti, prepracovane a doplnene vydani). Grada Publishing a. 2007, s 722
  2. Widimský J. Srdeční selhání, 2. roząířené a přepracované vydání, Triton 2003, s 556
  3. ©pinar J, Vítovec J. Chronické srdeční selhání, Medica s. r. o., Brno 2000, s 65
  4. Spinarova L,Toman J. Humoralni zmeny u chronickeho srdecniho selhani. Cor et Vasa 2001:43(10):5139
  5. Yanagisawa M, Kurihana H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:41115 Go to original source... Go to PubMed...
  6. Bartůněk L. Endoteliny a chronická srdeční insufi cience. Vnitřní Lékařství 2000; 46(1):5457
  7. Horký K. Patofyziologická úloha endotelinu u kardiovaskulárních onemocnění a moľnost jeho blokády. Remedia 1998; 8(6):408 416
  8. ©pinar J, Vítovec J, ©pinarová L, Toman J, Kubecová L, Pacher R, Stanek B, Wimmer A. The value of big endothelin level and hemodynamic variables in heart transplant candidates Cor et Vasa 2000; 42(10):495500
  9. Pacher R, Stanek B, Huelsman M, et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996; 27(3):633641 Go to original source... Go to PubMed...
  10. ©pinarová L, Toman J, Pospíąilová J, et al. Humoral response in patients with chronic heart failure. Int J Cardiol 1998; 65:227232 Go to original source... Go to PubMed...
  11. Zukowska-Grojec Z, Marks ES, Haass M. Neuropeptide Y is a potent vasoconstrictor and a cardiodepresssant in rat. Am J Physiol 1987; 253:H 1234 Go to PubMed...
  12. Castellani S, Paladini B, Paniccia R, et al. Increased renal formation of thromboxane A2 and prostaglandin F2 alpha in heart failure. Am Heart J 1997; 133:94100 Go to original source... Go to PubMed...
  13. Wijnbenga AAM, Balk AHM, Jonkman FAM et al. Relation of atrial natriuretic peptides to left ventricular systolic and diastolic function in heart failure. Eur J Heart Failure 1999; 1:5158 Go to original source... Go to PubMed...
  14. Sudoh T, Kangawa K, Minamino N et al. A natriuretic peptide in porcine brain. Nature 1988; 332:7881 Go to original source... Go to PubMed...
  15. Cowie MR, Struthers AD, Wood DA et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350:13491353 Go to original source... Go to PubMed...
  16. Vítovec J, ©pinarová L. Natriuretické peptidy-diagnostika a léčba. Remedia 2004;14(2):177181
  17. Oral I. Natriuretické peptidy současný stav klinického vyuľití jejich stanovení. Vnitřní Lék 2003; 49:521523
  18. Kalra PR, Anker SD, Struthers AD et al. The role of C type natriuretic peptide in cardiovascular medicine. Eur Heart J 2001; 22:9971007 Go to original source... Go to PubMed...
  19. Maisel AS, Krishnaswamy P et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis heart failure. N Eng J Med 2002; 347:161167 Go to original source... Go to PubMed...
  20. Spinar J, Vitovec J. Normy pro BNP a NT-pro BNP stanoveny. Cor et Vasa 2005;47(10):
  21. Hradec J. Mohou se stát natriuretické paptidy křią»álovou koulí kardiologa? JACC-CZ 2003; 5:255257
  22. Nieminen MS, Boehm M, Cowie MR et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005; 26:383416
  23. Swedberg K, Cleland J, Dargie H et al. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2005; 26:11151140
  24. Maisel A, McCord J, Nowak RM et al. Results from Breathing Not Properly Study (BNP). J Am Coll Cardiol 2003; 41:20102017
  25. Januzzi LJ, Camargo CA, Anwarudin S et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. J Am Coll Cardiol 2005; 95:948954 Go to original source...
  26. Harjola VP, Siirla-Waris K, Peuhkurinen K et al: FINN-AKVA Finnish Acute Heart Failure study-Prognostic signifi cance of NTproBNP as early follow-up. Abstract Book proCardio Symposium, 3rd International Symposium on NT-proBNP,May 2728,2005, Dresden, Germany
  27. Bettencourt P, Azevedo A, Pimenta J et al. N-terminal-pro-Brain Natriuretic Peptide predicts outcome after hospital discharge in heart failure patients. Circ 2004; 110:21682174 Go to original source... Go to PubMed...
  28. Staněk V. Kardiologie a biochemie. Znamenají natriuretické peptidy novou éru v diagnostice a kontrole léčby srdečního selhání. Cor Vasa 2002; 44:504505
  29. ©pinarová L, Toman J, Meluzín J, Hude P, Krejčí J, Tomandl J, Vítovec J. Natriuretic peptides and myocardial function in chronic heart failure. Eur J Echocard 2003; 4:Suppl.1:S 34 Go to original source...
  30. Petrie MC, McClure SJ, Love MP, et al. Novel neuropeptide in the pathophysiology of heart failure; adrenomedullin and endothelin-1. Eur J Heart Failure 1999; 1:2529 Go to original source... Go to PubMed...
  31. Funaya H, Kitakaze M, Node K, et al. Plasma adenosine levels increase in patients with chronic heart failure. Circulation 1997; 95:13631365 Go to original source... Go to PubMed...
  32. Pěnička M, Gregor P. Hypotéza kardiovaskulárních onemocnění. Postgraduální medicína 1999; 1:3443
  33. Niebauer J. Inflammatory mediators in heart failure. Int J of Cardiology 2000; 72:209213 Go to original source... Go to PubMed...
  34. Paulus WJ. How are cytokines activated in heart failure? Eur J Heart Fail 1999; 1:309312 Go to original source... Go to PubMed...
  35. Francis SE, Holden H, Holt CM. et al. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol 1998; 30:215230 Go to original source... Go to PubMed...

Return to the content